Certain regions of the SARS-CoV-2 genome might be a suitable target for future drugs, researchers have found. With the help of dedicated substance libraries, they have identified several small molecules that bind to certain areas of the SARS-CoV-2 genome that are almost never altered by mutations.
source https://www.sciencedaily.com/releases/2021/07/210720122337.htm
Wednesday, 21 July 2021
Related Posts
Discovery of a subset of human short introns spliced out by a distinct mechanismPre-mRNA splicing in a subset of human short introns is governed by a … Read More
'Missing jigsaw piece': Engineers make critical advance in quantum computer designA decades-old problem about how to reliably control millions of qubits… Read More
Inflatable robotic hand gives amputees real-time tactile controlAn MIT-developed inflatable robotic hand gives amputees real-time tact… Read More
A defective potassium channel disrupts the brain’s navigation systemThe potassium channel KCNQ3 is required for our brain to generate accu… Read More
Experimental drug that boosts immunotherapy shows promise in bladder cancer studyResearchers have found adding the experimental drug entinostat to an i… Read More
Table-top electron camera catches ultrafast dynamics of matterScientists have built a compact electron camera that can capture the i… Read More
0 comments: